The latest news from oncology events around the world
Long-term survival data from the first prospective, randomized biomarker validation trial in patients with muscle-invasive…
A new study suggests that an extensive genetic risk score could be an effective tool…
AUNZ’s largest oncology research organisation, Breast Cancer Trials are hosting a virtual Q&A on February…
When Sue (not her real name) was asked about being interviewed about living with metastatic…
Can you explain what metastatic breast cancer is? Metastatic breast cancer is the term used…
In this, large, phase 3 trial, ripretinib was not found to be better than sunitinib…
“The current standard of care for inoperable biliary tract cancer is combined chemotherapy. That standard…
“To date, the HIMALAYA study is one of the largest phase III studies conducted with…
New results for higher dose level cohorts of the investigational study REGN5458 (BCMAxCD3) bispecific antibody,…
Young patients with chronic lymphocytic leukaemia (CLL) can enjoy long remissions on the drug ibrutinib, but must stay on it indefinitely to…